A lawsuit is to be filed in Ireland against Johnson & Johnson subsidiary DePuy Othropaedics on behalf of more than 200 patients who had defective ASR hip replacement devices implanted between 2003 and 2010.
An attorney for the plaintiffs stated that approximately 3,500 people were affected by the devices. Their case against DePuy and J&J gained traction after the New York Times reported that one of the defective devices were shipped and sold throughout Europe and India after the FDA rejected them in the U.S. because of their failure rate.
The DePuy devices in question are the metal-on-metal implants, which have been shown to shed metal debris into the blood stream damaging nearby organs, tissue, muscle, and bone.
TheJournal.ie. reports that so far, 193 revision surgeries have been performed, and 100 more are scheduled to occur. DePuy claims 12 to 13 percent of implant patients will need revision surgery, but UK researchers estimate the figure to be closer to 50 per cent.
According to the attorney who filed the lawsuit, a “group action means we can band together to share scientific and medical information. Each case is very different though so will be looked at individually for compensation,” the Journal.ie. reported.